Skip to main content

Advertisement

SpringerLink
Log in

Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse

  • Research Article
  • Published:
Experimental Brain Research Aims and scope Submit manuscript

Abstract

One of the posttranslational modifications to proteins is methionine oxidation, which is readily reversible by the methionine sulfoxide reductase (Msr) system. Thus, accumulation of faulty proteins due to a compromised Msr system may lead to the development of aging-associated diseases like neurodegenerative diseases. In particular, it was interesting to monitor the consequential effects of methionine oxidation in relation to markers that are associated with Alzheimer’s disease as methionine oxidation was implied to play a role in beta-amyloid toxicity. In this study, a knockout mouse strain of the methionine sulfoxide reductase A gene (MsrA −/−) caused an enhanced neurodegeneration in brain hippocampus relative to its wild-type control mouse brain. Additionally, a loss of astrocytes integrity, elevated levels of beta-amyloid deposition, and tau phosphorylation were dominant in various regions of the MsrA −/− hippocampus but not in the wild-type. Also, a comparison between cultured brain slices of the hippocampal region of both mouse strains showed more sensitivity of the MsrA −/− cultured cells to H2O2 treatment. It is suggested that a deficiency in MsrA activity fosters oxidative-stress that is manifested by the accumulation of faulty proteins (via methionine oxidation), deposition of aggregated proteins, and premature brain cell death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Apelt J, Bigl M, Wunderlich P, Schliebs R (2004) Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int J Dev Neurosci 22:475–484

    Article  PubMed  CAS  Google Scholar 

  • Ashwood TJ, Lancaster B, Wheal HV (1984) In vivo and in vitro studies on putative interneurones in the rat hippocampus: possible mediators of feed-forward inhibition. Brain Res 293:279–291

    Article  PubMed  CAS  Google Scholar 

  • Blennow K, Vanmechelen E, Hampel H (2001) CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease. Mol Neurobiol 24:87–97

    Article  PubMed  CAS  Google Scholar 

  • Butterfield DA, Boyd-Kimball D (2005) The critical role of methionine 35 in Alzheimer’s amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703:149–156

    PubMed  CAS  Google Scholar 

  • Ciorba MA, Heinemann SH, Weissbach H, Brot N, Hoshi T (1997) Modulation of potassium channel function by methionine oxidation and reduction. Proc Natl Acad Sci USA 94:9932–9937

    Article  PubMed  CAS  Google Scholar 

  • Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR (2003) Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42:2768–2773

    Article  PubMed  CAS  Google Scholar 

  • Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Vinals F, Ribalta T (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol 11:144–158

    Article  PubMed  CAS  Google Scholar 

  • Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD, Koh JY, Bush AI (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer’s disease. J Neurosci 24:3453–3459

    Article  PubMed  CAS  Google Scholar 

  • Gabbita SP, Aksenov MY, Lovell MA, Markesbery WR (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer’s disease brain. J Neurochem 73:1660–1666

    Article  PubMed  CAS  Google Scholar 

  • Gamrani H, Onteniente B, Seguela P, Geffard M, Calas A (1986) Gamma-aminobutyric acid-immunoreactivity in the rat hippocampus. A light and electron microscopic study with anti-GABA antibodies. Brain Res 364:30–38

    Article  PubMed  CAS  Google Scholar 

  • Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y (2004) Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem 279:44795–44801

    Article  PubMed  CAS  Google Scholar 

  • Hol EM, Roelofs RF, Moraal E, Sonnemans MA, Sluijs JA, Proper EA, de Graan PN, Fischer DF, van Leeuwen FW (2003) Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry 8:786–796

    Article  PubMed  CAS  Google Scholar 

  • Hyman BT, Elvhage TE, Reiter J (1994a) Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer’s disease. Am J Pathol 144:565–572

    CAS  Google Scholar 

  • Hyman BT, Reiter J, Moss M, Rosene D, Pandya D (1994b) Extracellular signal-regulated kinase (MAP kinase) immunoreactivity in the rhesus monkey brain. Neurosci Lett 166:113–116

    Article  CAS  Google Scholar 

  • Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62:925–931

    PubMed  CAS  Google Scholar 

  • Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y (2002) Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 277:24049–24056

    Article  PubMed  CAS  Google Scholar 

  • Knowles WD, Schwartzkroin PA (1981) Local circuit synaptic interactions in hippocampal brain slices. J Neurosci 1:318–322

    PubMed  CAS  Google Scholar 

  • Kunkel DD, Hendrickson AE, Wu JY, Schwartzkroin PA (1986) Glutamic acid decarboxylase (GAD) immunocytochemistry of developing rabbit hippocampus. J Neurosci 6:541–552

    PubMed  CAS  Google Scholar 

  • Levine RL, Moskovitz J, Stadtman ER (2000) Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 50:301–307

    Article  PubMed  CAS  Google Scholar 

  • Mohri M, Reinach PS, Kanayama A, Shimizu M, Moskovitz J, Hisatsune T, Miyamoto Y (2002) Suppression of the TNFalpha-induced increase in IL-1alpha expression by hypochlorite in human corneal epithelial cells. Invest Ophthalmol Vis Sci 43:3190–3195

    PubMed  Google Scholar 

  • Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in “normal” aging: Evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 46:707–719

    PubMed  CAS  Google Scholar 

  • Moskovitz J (2005) Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta 1703:213–219

    PubMed  CAS  Google Scholar 

  • Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA 98:12920–12925

    Article  PubMed  CAS  Google Scholar 

  • Moskovitz J, Berlett BS, Poston JM, Stadtman ER (1997) The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc Natl Acad Sci USA 94:9585–9589

    Article  PubMed  CAS  Google Scholar 

  • Moskovitz J, Flescher E, Berlett BS, Azare J, Poston JM, Stadtman ER (1998) Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Natl Acad Sci USA 95:14071–14075

    Article  PubMed  CAS  Google Scholar 

  • Moskovitz J, Rahman MA, Strassman J, Yancey SO, Kushner SR, Brot N, Weissbach H (1995) Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage. J Bacteriol 177:502–507

    PubMed  CAS  Google Scholar 

  • Mouser PE, Head E, Ha KH, Rohn TT (2006) Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer’s disease brain. Am J Pathol 168:936–946

    Article  PubMed  CAS  Google Scholar 

  • Palmblad M, Westlind-Danielsson A, Bergquist J (2002) Oxidation of methionine 35 attenuates formation of amyloid beta-peptide 1–40 oligomers. J Biol Chem 277:19506–19510

    Article  PubMed  CAS  Google Scholar 

  • Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer’s disease. Brain Res Mol Brain Res 109:45–55

    Article  PubMed  CAS  Google Scholar 

  • Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10:2411–2415

    Article  PubMed  CAS  Google Scholar 

  • Ribak CE, Vaughn JE, Saito K (1978) Immunocytochemical localization of glutamic acid decarboxylase in neuronal somata following colchicine inhibition of axonal transport. Brain Res 140:315–332

    Article  PubMed  CAS  Google Scholar 

  • Romero HM, Berlett BS, Jensen PJ, Pell EJ, Tien M (2004) Investigations into the role of the plastidial peptide methionine sulfoxide reductase in response to oxidative stress in Arabidopsis. Plant Physiol 136:3784–3794

    Article  PubMed  CAS  Google Scholar 

  • Ruan H, Tang XD, Chen ML, Joiner ML, Sun G, Brot N, Weissbach H, Heinemann SH, Iverson L, Wu CF, Hoshi T (2002) High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 99:2748–2753

    Article  PubMed  CAS  Google Scholar 

  • Schoneich C (2005) Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer’s disease. Biochim Biophys Acta 1703:111–119

    PubMed  Google Scholar 

  • Schwartzkroin PA, Mathers LH (1978) Physiological and morphological identification of a nonpyramidal hippocampal cell type. Brain Res 157:1–10

    Article  PubMed  CAS  Google Scholar 

  • Stadtman ER, Moskovitz J, Levine RL (2003) Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal 5:577–582

    Article  PubMed  CAS  Google Scholar 

  • Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173–182

    Article  PubMed  CAS  Google Scholar 

  • Su Y, Ni B (1998) Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer’s disease. J Neurosci Res 53:177–186

    Article  PubMed  CAS  Google Scholar 

  • Sun H, Gao J, Ferrington DA, Biesiada H, Williams TD, Squier TC (1999) Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry 38:105–112

    Article  PubMed  CAS  Google Scholar 

  • Trojanowski JQ, Mawal-Dewan M, Schmidt ML, Martin J, Lee VM (1993) Localization of the mitogen activated protein kinase ERK2 in Alzheimer’s disease neurofibrillary tangles and senile plaque neurites. Brain Res 618:333–337

    Article  PubMed  CAS  Google Scholar 

  • Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, Fink AL (2002) Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett 517:239–244

    Article  PubMed  CAS  Google Scholar 

  • Yamin G, Glaser CB, Uversky VN, Fink AL (2003) Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein. J Biol Chem 278:27630–27635

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the J.R. and Inez Jay fund and Higuchi Biosciences Center at University of Kansas for supporting this study.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA

    Ranu Pal, Derek B. Oien, Fatma Y. Ersen & Jackob Moskovitz

Authors
  1. Ranu Pal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derek B. Oien
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatma Y. Ersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jackob Moskovitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jackob Moskovitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pal, R., Oien, D.B., Ersen, F.Y. et al. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res 180, 765–774 (2007). https://doi.org/10.1007/s00221-007-0903-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00221-007-0903-6

Keywords

Search

Navigation